764
Views
12
CrossRef citations to date
0
Altmetric
Review

New approaches in the management of multiple sclerosis

, , &
Pages 343-366 | Published online: 24 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Reza Nosratabadi, Maryam Rastin, Mojtaba Sankian, Dariush Haghmorad, Nafiseh Tabasi, Shahrzad Zamani, Azita Aghaee, Zohre Salehipour & Mahmoud Mahmoudi. (2016) St. John’s wort and its component hyperforin alleviate experimental autoimmune encephalomyelitis through expansion of regulatory T-cells. Journal of Immunotoxicology 13:3, pages 364-374.
Read now

Articles from other publishers (10)

Pınar KAYA CİDDİ. (2023) Psychosocial Aspects of Rehabilitation in Neurodegenerative Diseases and Fields of ApproachNörodejeneratif Hastalıklarda Rehabilitasyonun Psikososyal Yönleri ve Yaklaşım Alanları. Psikiyatride Güncel Yaklaşımlar 15:3, pages 385-397.
Crossref
Daphne Kos, Isaline Eijssen, Geertruida E Bekkering, Leen De Coninck, Ciara O'Meara, Marja Koen & Sinéad M Hynes. (2023) Occupational therapy in multiple sclerosis. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Saneela Tahseen & Shahid Bashir. 2023. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases. Medical Cannabis and the Effects of Cannabinoids on Fighting Cancer, Multiple Sclerosis, Epilepsy, Parkinson's, and Other Neurodegenerative Diseases 187 216 .
Alessandro de Sire, Lucrezia Moggio, Nicola Marotta, Francesco Fortunato, Renata Spalek, Maria Teresa Inzitari, Teresa Paolucci & Antonio Ammendolia. (2022) Ultrasound-Guided Injections and Proprioceptive Neuromuscular Facilitation as Shoulder Rehabilitation for Multiple Sclerosis and Neuropathic Pain. Healthcare 10:10, pages 1869.
Crossref
S. A. Ryabov & A. N. Boyko. (2020) Rehabilitation of patients with multiple sclerosis in terms of evidence-based medicine: techniques for digitizing the results. Neurology, Neuropsychiatry, Psychosomatics 12:1S, pages 38-43.
Crossref
Christopher P. Dwyer, Alberto Alvarez-Iglesias, Robert Joyce, Timothy J. Counihan, Dympna Casey & Sinéad M. Hynes. (2020) Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial. Trials 21:1.
Crossref
N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt & M. V. Shumilina. (2019) Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects». Neurology, Neuropsychiatry, Psychosomatics 11:4, pages 172-175.
Crossref
Gabriel Pardo & David E. Jones. (2017) The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. Journal of Neurology 264:12, pages 2351-2374.
Crossref
Yuki Fujita & Toshihide Yamashita. (2014) Axon growth inhibition by RhoA/ROCK in the central nervous system. Frontiers in Neuroscience 8.
Crossref
Shyi-Jou Chen, Yen-Ling Wang, Hueng-Chuen Fan, Wen-Tsung Lo, Chih-Chien Wang & Huey-Kang Sytwu. (2012) Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis. Clinical and Developmental Immunology 2012, pages 1-16.
Crossref